Mikart, Inc.

FDA inspection history across 2 sites, 2002 to 2021

1
Close-out
1
Form 483
1
Warning letter

Every document, by year

  • Close-out
  • Form 483
  • Warning letter

2002: one warning letter; 2019: one Form 483; 2021: one close-out letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2002One warning letter, at Atlanta, Georgia.
  2. 2019–21One Form 483 and one close-out letter, at Atlanta, Georgia and Cincinnatti, Ohio.

Cited most

Across all Mikart observations on file

The complete Mikart file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2021-11-17Close-out Close-out letter$99
2019-01-18483 Form 483$99
2002-10-11Warning letter Warning letter$99

Investigators on these documents

Rachael L. Cook (1)

FEI number 1050658 · most recent document Nov 17, 2021

About Mikart, Inc.

How many FDA Form 483s has Mikart, Inc. received?

FDA Intel has 1 Form 483 on file for Mikart, Inc.; the most recent is dated Jan 18, 2019.

When was Mikart, Inc. last inspected by FDA?

The most recent FDA inspection document on file for Mikart, Inc. is a Form 483 dated Jan 18, 2019, for the site in Atlanta, Georgia.

What did FDA cite at Mikart, Inc.?

The regulations cited most in the observations on file for Mikart, Inc. are 21 CFR 211.25(a) (Personnel qualifications), 1 time; 21 CFR 211.82(b) (Receipt and storage of untested components, drug product containers, and closures), 1 time.

Has Mikart, Inc. received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Mikart, Inc.; the most recent is dated Oct 11, 2002.